Sertraline Hydrochloride Capsule
Product Images NDC 69097-451

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 69097-451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (150 mg)

This text provides important information about a prescription drug called Sertraline HCI Capsules. It includes details such as the active ingredient, recommended dosage, storage instructions, manufacturer information, and the presence of FDAC Yellow No. 5. The medication guide should be dispensed to each patient. The drug is manufactured for Cipla USA, Inc. in India. Additionally, it contains 30 capsules, each containing 168 mg of sertraline hydrochloride, equivalent to 150 mg of sertraline. Storage temperature recommendations are also provided.*

FDA Label Image

Image Description (200 mg)

This text provides important information about Sertraline HCl capsules manufactured by Zenara Pharma Private Limited in India for Cipla USA, Inc. It includes details on recommended dosage, storage conditions, and the presence of FDAC Yellow No. 5 as a color additive. Pharmacies are instructed to dispense the medication guide with each patient's prescription. The text also indicates the lot number, expiration date, and unique coding information for the product.*

FDA Label Image

Formula (Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.